YU59890A - Antibacteria 2-carbapenem derivatives - Google Patents

Antibacteria 2-carbapenem derivatives

Info

Publication number
YU59890A
YU59890A YU00598/90A YU59890A YU59890A YU 59890 A YU59890 A YU 59890A YU 00598/90 A YU00598/90 A YU 00598/90A YU 59890 A YU59890 A YU 59890A YU 59890 A YU59890 A YU 59890A
Authority
YU
Yugoslavia
Prior art keywords
pref
antibacteria
methyl
formula
carbapenem derivatives
Prior art date
Application number
YU00598/90A
Other languages
English (en)
Inventor
J J Vytautas
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU59890A publication Critical patent/YU59890A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
YU00598/90A 1989-03-28 1990-03-27 Antibacteria 2-carbapenem derivatives YU59890A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/001281 WO1990011284A1 (en) 1989-03-28 1989-03-28 Antibacterial 2-carbapenem derivatives

Publications (1)

Publication Number Publication Date
YU59890A true YU59890A (en) 1991-10-31

Family

ID=22214911

Family Applications (1)

Application Number Title Priority Date Filing Date
YU00598/90A YU59890A (en) 1989-03-28 1990-03-27 Antibacteria 2-carbapenem derivatives

Country Status (24)

Country Link
EP (1) EP0392681B1 (xx)
JP (1) JPH02286681A (xx)
KR (1) KR920002132B1 (xx)
CN (1) CN1024554C (xx)
AT (1) ATE100104T1 (xx)
AU (1) AU616345B2 (xx)
CA (1) CA2013024A1 (xx)
DD (1) DD293117A5 (xx)
DE (1) DE69005875T2 (xx)
DK (1) DK0392681T3 (xx)
EG (1) EG19079A (xx)
ES (1) ES2062340T3 (xx)
FI (1) FI914558A0 (xx)
HU (2) HU209817B (xx)
IE (1) IE901105L (xx)
IL (1) IL93835A0 (xx)
MX (1) MX20084A (xx)
NO (1) NO913815L (xx)
NZ (1) NZ233093A (xx)
PH (1) PH26902A (xx)
PT (1) PT93565A (xx)
WO (1) WO1990011284A1 (xx)
YU (1) YU59890A (xx)
ZA (1) ZA902347B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
US5602118A (en) * 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619924A (en) * 1984-05-18 1986-10-28 Pfizer Inc. 2-alkylthiopenem derivatives
US4757066A (en) * 1984-10-15 1988-07-12 Sankyo Company Limited Composition containing a penem or carbapenem antibiotic and the use of the same
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
EP0223397B1 (en) * 1985-10-17 1991-09-04 Pfizer Inc. Process for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics
DE3775504D1 (en) * 1986-09-04 1992-02-06 Pfizer 2-(1-oxo-1-imino-1-thiacycloalkyl)-thiopenem-derivate.
US5013729A (en) * 1987-05-11 1991-05-07 Pfizer Inc. Diastereomeric 5R,6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids

Also Published As

Publication number Publication date
EP0392681B1 (en) 1994-01-12
ZA902347B (en) 1991-11-27
NZ233093A (en) 1992-01-29
ATE100104T1 (de) 1994-01-15
ES2062340T3 (es) 1994-12-16
JPH02286681A (ja) 1990-11-26
FI914558A0 (fi) 1991-09-27
AU616345B2 (en) 1991-10-24
CA2013024A1 (en) 1990-09-28
IE901105L (en) 1990-09-28
DE69005875T2 (de) 1994-04-28
HU209817B (en) 1994-11-28
CN1046164A (zh) 1990-10-17
EG19079A (en) 1994-04-30
AU5229390A (en) 1990-10-04
DE69005875D1 (de) 1994-02-24
KR920002132B1 (ko) 1992-03-12
KR900014384A (ko) 1990-10-23
HUT63167A (en) 1993-07-28
PH26902A (en) 1992-12-03
CN1024554C (zh) 1994-05-18
HU895565D0 (en) 1992-07-28
IL93835A0 (en) 1990-12-23
NO913815D0 (no) 1991-09-27
NO913815L (no) 1991-11-27
WO1990011284A1 (en) 1990-10-04
EP0392681A1 (en) 1990-10-17
DD293117A5 (de) 1991-08-22
DK0392681T3 (da) 1994-03-21
HUT64070A (en) 1993-11-29
PT93565A (pt) 1990-11-07
MX20084A (es) 1993-03-01

Similar Documents

Publication Publication Date Title
NO180407C (no) Anvendelse av 1,3-oksatiolannukleosidanaloger ved fremstilling av et medikament for behandling av hepatitt B
GR3030165T3 (en) N-heteroaryl-n'-phenylurea derivatives, their production and use.
AU3213795A (en) Endothelin antagonists
AU4497293A (en) Phenoxy- and phenoxyalkyl-piperidines as antiviral agents
GR3032220T3 (en) Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives for the treatment of diseases which are mediated by non-enzymatical glycosylation
AU1302388A (en) Method of treating anxiety with tetrahydrobenz(c,d)indole-6- carboxamides
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
AU6653690A (en) Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
YU59890A (en) Antibacteria 2-carbapenem derivatives
EP0760362A4 (en) NEW DIAMINOMETHYLIDES DERIVATIVES
NZ229186A (en) 4-(1-(2-carboxy-3-(2-methoxyethoxy)propyl)-1-cyclopentane-
EP0001715A3 (en) Azetidinone antibiotics and their pharmaceutical formulations and use
AU613821B2 (en) 6-beta(substituted)-(s)-hydroxymethylpenicillanic acids and derivatives thereof
GB9015485D0 (en) Heterocyclic derivatives
MX9706187A (es) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas.